Literature DB >> 33168589

Gastric Metabolomics Detects Helicobacter pylori Correlated Loss of Numerous Metabolites in Both the Corpus and Antrum.

Daniela Keilberg1, Nina Steele2, Sili Fan3, Christina Yang1, Yana Zavros2, Karen M Ottemann4.   

Abstract

Helicobacter pylori is a chronic bacterial pathogen that thrives in several regions of the stomach, causing inflammation that can vary by site and result in distinct disease outcomes. Whether the regions differ in terms of host-derived metabolites is not known. We thus characterized the regional variation of the metabolomes of mouse gastric corpus and antrum organoids and tissue. The uninfected secreted organoid metabolites differed between the corpus and antrum in only seven metabolites as follows: lactic acid, malic acid, phosphoethanolamine, alanine, uridine, glycerol, and isoleucine. Several of the secreted chemicals were depleted upon H. pylori infection in both regions, including urea, cholesterol, glutamine, fumaric acid, lactic acid, citric acid, malic acid, and multiple nonessential amino acids. These results suggest a model in which H. pylori preferentially uses carboxylic acids and amino acids in complex environments, and these are found in both the corpus and antrum. When organoid metabolites were compared to mouse tissue, there was little overlap. The tissue corpus and antrum metabolomes were distinct, including antrum-elevated 5-methoxytryptamine, lactic acid, and caprylic acid, and corpus-elevated phospholipid products. The corpus and antrum remained distinct over an 8-month infection time course. The antrum displayed no significant changes between the time points in contrast to the corpus, which exhibited metabolite changes that were consistent with stress, tissue damage, and depletion of key nutrients, such as glutamine and fructose-6-phosphate. Overall, our results suggest that the corpus and antrum have largely but not completely overlapping metabolomes that change moderately upon H. pylori infection.
Copyright © 2021 American Society for Microbiology.

Entities:  

Keywords:  carbon metabolism; gastric; organoid

Mesh:

Year:  2021        PMID: 33168589      PMCID: PMC7822133          DOI: 10.1128/IAI.00690-20

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  Adenosine and gastrointestinal inflammation.

Authors:  Sean P Colgan; Blair Fennimore; Stefan F Ehrentraut
Journal:  J Mol Med (Berl)       Date:  2013-01-08       Impact factor: 4.599

2.  Coupled amino acid deamidase-transport systems essential for Helicobacter pylori colonization.

Authors:  Damien Leduc; Julien Gallaud; Kerstin Stingl; Hilde de Reuse
Journal:  Infect Immun       Date:  2010-04-05       Impact factor: 3.441

3.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

4.  A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain.

Authors:  A Lee; J O'Rourke; M C De Ungria; B Robertson; G Daskalopoulos; M F Dixon
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

5.  L-lactic acid secreted from gastric mucosal cells enhances growth of Helicobacter pylori.

Authors:  Tetsufumi Takahashi; Tsukasa Matsumoto; Masahiko Nakamura; Hidenori Matsui; Kanji Tsuchimoto; Haruki Yamada
Journal:  Helicobacter       Date:  2007-10       Impact factor: 5.753

Review 6.  The physiology and metabolism of the human gastric pathogen Helicobacter pylori.

Authors:  D J Kelly
Journal:  Adv Microb Physiol       Date:  1998       Impact factor: 3.517

Review 7.  The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases.

Authors:  John C Atherton
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

8.  Metabolomics by Gas Chromatography-Mass Spectrometry: Combined Targeted and Untargeted Profiling.

Authors:  Oliver Fiehn
Journal:  Curr Protoc Mol Biol       Date:  2016-04-01

Review 9.  CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers.

Authors:  Jerry B Harvey; Luan H Phan; Oscar E Villarreal; Jessica L Bowser
Journal:  Front Immunol       Date:  2020-04-15       Impact factor: 7.561

10.  Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets.

Authors:  Dinesh Kumar Barupal; Oliver Fiehn
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

View more
  4 in total

Review 1.  Gastric organoids: Advancing the study of H. pylori pathogenesis and inflammation.

Authors:  Sulaimon Idowu; Paul P Bertrand; Anna K Walduck
Journal:  Helicobacter       Date:  2022-04-05       Impact factor: 5.182

2.  Genome-wide association study of gastric cancer- and duodenal ulcer-derived Helicobacter pylori strains reveals discriminatory genetic variations and novel oncoprotein candidates.

Authors:  Vo Phuoc Tuan; Koji Yahara; Ho Dang Quy Dung; Tran Thanh Binh; Pham Huu Tung; Tran Dinh Tri; Ngo Phuong Minh Thuan; Vu Van Khien; Tran Thi Huyen Trang; Bui Hoang Phuc; Evariste Tshibangu-Kabamba; Takashi Matsumoto; Junko Akada; Rumiko Suzuki; Tadayoshi Okimoto; Masaaki Kodama; Kazunari Murakami; Hirokazu Yano; Masaki Fukuyo; Noriko Takahashi; Mototsugu Kato; Shin Nishiumi; Takashi Azuma; Yoshitoshi Ogura; Tetsuya Hayashi; Atsushi Toyoda; Ichizo Kobayashi; Yoshio Yamaoka
Journal:  Microb Genom       Date:  2021-11

3.  Different Metabolites of the Gastric Mucosa between Patients with Current Helicobacter pylori Infection, Past Infection, and No Infection History.

Authors:  Su-Young Son; Choong-Hwan Lee; Sun-Young Lee
Journal:  Biomedicines       Date:  2022-02-26

4.  The dCache Chemoreceptor TlpA of Helicobacter pylori Binds Multiple Attractant and Antagonistic Ligands via Distinct Sites.

Authors:  Kevin S Johnson; Bassam A Elgamoudi; Freda E-C Jen; Christopher J Day; Emily Goers Sweeney; Megan L Pryce; Karen Guillemin; Thomas Haselhorst; Victoria Korolik; Karen M Ottemann
Journal:  mBio       Date:  2021-08-03       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.